1Kern W ,Scheyer E , Unterhah M. High antileukemic activity of sequential high dose cytosine arabinoside and mitox-antrone in refractor), acute leukemia: result of a clinical phase II study.Cancer, 1997,79:59.
2Barrios NJ, Tebbi CK, Freeman AI, et al. Toxicity of highdose Ara-C in children and adolescents. Cancer, 1987,60:165.
3Kern W , Aul C, Maschmeyer G. Ganulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongsdisease-free survival after sequential high-dosee cytosine arabinoside and mitox-antrone (S-HAM)salvage therapy for refractory, and relapsed acute myeloid leukemia. Ann Hematol,1998,77:115.
4Schwartz J .Visual loss following high-dose cytosine arabinoside(ARA-C).Eur J Haematol,2000,64:208.
5Damon LE, Mass R, Linker CA, The association between high -dose cytarabine nurotoxicity and renal insufficiency.J Clin Onco1,1989,7(10):1563.
6Coppizi RL. Curative chemotherapy for acute myeloid leukemia:The development of high dose Ara-C from the laboratory to bedside. Invest New Drugs,1996,14:249.
